ACSL4 is a predictive biomarker of sorafenib sensitivity in hepatocellular carcinomaFeng Ji, Guo‐Dong Lu|Acta Pharmacologica Sinica|2020Cited by 161
Activating AMP-activated protein kinase by an α1 selective activator compound 13 attenuates dexamethasone-induced osteoblast cell deathShiguang Guo, Xiaodong Wang, Shouguo Wang et al.|Biochemical and Biophysical Research Communications|2016Cited by 59
PP2A catalytic subunit silence by microRNA-429 activates AMPK and protects osteoblastic cells from dexamethasoneShiguang Guo, Yue Xie, Caiyun Chen et al.|Biochemical and Biophysical Research Communications|2017Cited by 45
Targeted activation of AMPK by GSK621 ameliorates H2O2-induced damages in osteoblastsWeidong Liu, Gang Liu, Yuedong Hao et al.|Oncotarget|2017Cited by 40